Dalil Hamroun
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Increased intervals in enzyme replacement therapy for stable type 1 Gaucher disease: A non-inferiority sequential trial emulation.
Journal: Journal of internal medicine
Published: February 28, 2026
The 2026 version of the gene table of neuromuscular disorders (nuclear genome).
Journal: Neuromuscular disorders : NMD
Published: December 25, 2025
Real-Life Effectiveness After Switching to Avalglucosidase Alfa in Late-Onset Pompe Disease Patients Worsening on Alglucosidase Alfa Therapy: A French Cohort Study.
Journal: European journal of neurology
Published: November 23, 2025
Causes of Death and Comorbidities in Adult Patients With Late-Onset Pompe Disease: A French Pompe Registry Retrospective Study.
Journal: European journal of neurology
Published: May 20, 2025
Evaluating a predictive model of tyrosine kinase inhibitor therapy failure in a European-type cohort: a step towards population-specific tools.
Journal: Leukemia
Published: April 28, 2025
The 2025 version of the gene table of neuromuscular disorders (nuclear genome).
Journal: Neuromuscular disorders : NMD
Published: January 31, 2025
Epidemiology of Gaucher Disease in France: Trends in Incidence, Mortality, Management, and Complications Over Three Decades.
Journal: Journal of inherited metabolic disease
Published: January 30, 2025
Never-Treated, Non Splenectomised Patients With Gaucher Disease (The French GANT Study): The Prospective Follow-Up.
Journal: Journal of inherited metabolic disease
Published: December 19, 2024
Bulbar muscle impairment in patients with late onset Pompe disease: Insight from the French Pompe registry.
Journal: European journal of neurology
Published: February 13, 2024
The 2024 version of the gene table of neuromuscular disorders (nuclear genome).
Journal: Neuromuscular disorders : NMD
Published: January 22, 2024
The initial molecular response predicts the deep molecular response but not treatment-free remission maintenance in a real-world chronic myeloid leukemia cohort.
Journal: Haematologica
Published: December 19, 2023
EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders.
Journal: Orphanet journal of rare diseases
Published: June 12, 2023
Last Updated: 09/26/2026